Management of Sepsis and Septic Shock 2026

Problem

High sepsis mortality in Egypt; delayed recognition in many hospitals.

Benefit

Early detection, standardized treatment, improved survival.

Risk/Harm

Minimal; requires training and resources.

Certainty of Evidence

High.

Values & Preferences

Patients value rapid diagnosis and treatment.

Resource Use

Moderate; requires staff training and monitoring systems.

Equity

Improves care across diverse hospitals.

Acceptability

High among clinicians and administrators.

Feasibility

Feasible with phased implementation.

Recommendation

Strong: Implement sepsis performance improvement programs, including screening and SOPs.

Problem

Delayed antibiotics linked to higher mortality.

Benefit

Early antibiotics reduce mortality in septic shock.

Risk/Harm

Overuse may drive resistance.

Certainty of Evidence

High for septic shock; moderate for sepsis without shock.

Values & Preferences

Patients prioritize survival over resistance concerns.

Resource Use

Moderate; requires rapid access to antimicrobials.

Equity

Critical in rural/low-resource hospitals.

Acceptability

High among clinicians.

Feasibility

Feasible with stock management and protocols.

Recommendation

Strong: Administer antimicrobials within 1 hour for septic shock; within 3 hours for possible sepsis without shock.

Problem

Delayed source control worsens outcomes.

Benefit

Early intervention reduces mortality.

Risk/Harm

Procedural risks (surgery, drainage).

Certainty of Evidence

Moderate.

Values & Preferences

Patients value rapid relief of the infection source.

Resource Use

High; requires surgical/IR availability.

Equity

Limited in rural hospitals.

Acceptability

High among clinicians.

Feasibility

Feasible in tertiary centers; challenging in district hospitals.

Recommendation

Conditional: Early source control within 6 hours.

Problem

Overuse of broad-spectrum antimicrobials.

Benefit

Reduces resistance, improves stewardship.

Risk/Harm

Risk of undertreatment if misapplied.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value safety and survival.

Resource Use

Low; requires culture facilities.

Equity

Limited in hospitals without microbiology labs.

Acceptability

High among stewardship advocates.

Feasibility

Feasible with daily review.

Recommendation

Strong: De-escalate antimicrobials when culture results available.

Problem

Hypoperfusion and shock are common in Egyptian ICUs.

Benefit

30 ml/kg crystalloid improves perfusion.

Risk/Harm

Risk of fluid overload, especially in elderly/CHF patients.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value survival; clinicians cautious about overload.

Resource Use

Low; crystalloids widely available.

Equity

Accessible in most hospitals.

Acceptability

High.

Feasibility

Feasible with monitoring.

Recommendation

Conditional: Administer 30 ml/kg crystalloid within 3 hours, with reassessment.

Problem

Persistent hypotension after fluids.

Benefit

Restores MAP, reduces mortality.

Risk/Harm

Peripheral administration risks extravasation.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value stabilization.

Resource Use

Moderate; requires vasopressor availability.

Equity

Limited in rural hospitals.

Acceptability

High.

Feasibility

Feasible with training.

Recommendation

Conditional: Start vasopressors peripherally if central access delayed; target MAP 65 mmHg.

Problem

Choice of resuscitation fluid impacts renal outcomes and mortality.

Benefit

Balanced crystalloids reduce risk of hyperchloremic acidosis and renal injury.

Risk/Harm

Saline may worsen acidosis; balanced solutions may be contraindicated in TBI.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value survival and renal protection.

Resource Use

Balanced crystalloids slightly more costly but widely available.

Equity

Accessible in tertiary hospitals; limited in rural centers.

Acceptability

High among intensivists.

Feasibility

Feasible with procurement planning.

Recommendation

Conditional: Use balanced crystalloids over saline, except in TBI

Problem

Fluid overload risk after large crystalloid volumes.

Benefit

Albumin may improve oncotic pressure in cirrhosis or hypoalbuminemia.

Risk/Harm

Expensive; avoid in TBI.

Certainty of Evidence

Low.

Values & Preferences

Patients value reduced edema and improved perfusion.

Resource Use

High cost; limited availability in Egypt.

Equity

May widen gap between tertiary and district hospitals.

Acceptability

Moderate among clinicians.

Feasibility

Limited in resource-constrained settings.

Recommendation

Conditional: Consider albumin in selected patients after large crystalloid volumes or cirrhosis.

Problem

Static measures (CVP) unreliable for guiding fluids.

Benefit

Dynamic measures improve the precision of resuscitation.

Risk/Harm

Requires monitoring equipment and training.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value tailored resuscitation.

Resource Use

Moderate; requires monitors.

Equity

Limited in rural hospitals.

Acceptability

High among critical care teams.

Feasibility

Feasible in ICUs with monitoring capacity.

Recommendation

Conditional: Use dynamic measures (passive leg raise, SVV, PPV) over static measures.

Problem

Hypoxemia common in sepsis.

Benefit

Supplemental oxygen improves tissue oxygenation.

Risk/Harm

Hyperoxia may increase oxidative stress.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value relief of dyspnea and survival.

Resource Use

Low; oxygen widely available.

Equity

Accessible in most Egyptian hospitals.

Acceptability

High.

Feasibility

Feasible with standard oxygen delivery systems.

Recommendation

Strong: Provide supplemental oxygen to maintain SPO2 ≥ 90%.

Problem

Patients with hypoxemic respiratory failure may deteriorate.

Benefit

HFNO reduces the need for intubation in selected patients.

Risk/Harm

Requires equipment; may delay intubation if misused.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value comfort and avoidance of intubation.

Resource Use

Higher cost; limited availability in Egypt.

Equity

Available in tertiary centers; limited in district hospitals.

Acceptability

High among intensivists.

Feasibility

Feasible in ICUs with HFNO devices.

Recommendation

Conditional: Use HFNO in hypoxemic respiratory failure when available.

Problem

NIV may prevent intubation in selected patients.

Benefit

Reduces complications of invasive ventilation.

Risk/Harm

Risk of delayed intubation and aspiration.

Certainty of Evidence

Low.

Values & Preferences

Patients value the avoidance of intubation.

Resource Use

Moderate; requires trained staff.

Equity

Limited in rural hospitals.

Acceptability

Moderate among clinicians.

Feasibility

Feasible in ICUs with NIV capability.

Recommendation

Conditional: Consider NIV in selected patients with sepsis-related respiratory failure, with close monitoring.

Problem

Severe sepsis often requires intubation.

Benefit

Ensures oxygenation and ventilation.

Risk/Harm

Ventilator-associated complications.

Certainty of Evidence

High.

Values & Preferences

Patients value survival despite risks.

Resource Use

High; requires ICU infrastructure.

Equity

Limited in district hospitals.

Acceptability

High among intensivists.

Feasibility

Feasible in tertiary ICUs.

Recommendation

Strong: Provide invasive mechanical ventilation when indicated, with lung-protective strategies.

Problem

Refractory hypoxemia despite optimal mechanical ventilation.

Benefit

Provides extracorporeal oxygenation and CO2 removal, bridging patients through severe ARDS or septic respiratory failure.

Risk/Harm

High risk of bleeding, thrombosis, infection; requires specialized expertise.

Certainty of Evidence

Low (benefit in selected patients).

Values & Preferences

Patients and families value survival in otherwise fatal scenarios.

Resource Use

Very high; requires ECMO circuits, perfusionists, and specialized ICU teams.

Equity

Limited to tertiary centers in Egypt; not feasible in most hospitals.

Acceptability

High among ECMO-capable centers.

Feasibility

Feasible only in specialized ICUs with ECMO programs.

Recommendation

Conditional: Consider VV-ECMO in refractory hypoxemia unresponsive to optimal mechanical ventilation, in centers with expertise.

Problem

Persistent hypotension despite fluids and vasopressors.

Benefit

Shortens duration of shock, may reduce vasopressor requirement.

Benefit Direction

Positive – stabilizes circulation, improves shock resolution.

Risk/Harm

Hyperglycemia, secondary infections, and muscle weakness.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value stabilization and survival.

Resource Use

Low; widely available.

Equity

Accessible in most Egyptian hospitals.

Acceptability

High among intensivists.

Feasibility

Feasible with monitoring.

Recommendation

Conditional: Consider IV corticosteroids in refractory septic shock.

Problem

Oxidative stress and endothelial dysfunction in sepsis.

Benefit

Proposed antioxidant and vasopressor-sparing effects.

Benefit Direction

Neutral/uncertain – evidence inconsistent, no proven survival benefit.

Risk/Harm

Risk of oxalate nephropathy at high doses.

Certainty of Evidence

Low.

Values & Preferences

Patients value innovative therapies.

Resource Use

Moderate cost.

Equity

Limited availability.

Acceptability

Moderate.

Feasibility

Feasible in tertiary centers.

Recommendation

Conditional: No routine use; consider only in research settings.

Problem

Critically ill patients at risk of GI bleeding.

Benefit

Reduces the incidence of stress-related mucosal bleeding.

Benefit Direction

Positive – prevents GI bleeding in high-risk patients.

Risk/Harm

Increased risk of pneumonia, C. difficile.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value the prevention of bleeding.

Resource Use

Low.

Equity

Widely available.

Acceptability

High.

Feasibility

Feasible with standard ICU protocols.

Recommendation

Conditional: Use prophylaxis in patients with risk factors (mechanical ventilation >48h, coagulopathy).

Problem

Fluid overload after resuscitation.

Benefit

Improves oxygenation, reduces edema.

Benefit Direction

Positive – improves organ function by reducing overload.

Risk/Harm

Risk of hypoperfusion, electrolyte imbalance.

Certainty of Evidence

Low.

Values & Preferences

Patients value comfort and reduced edema.

Resource Use

Moderate.

Equity

Limited in rural hospitals.

Acceptability

Moderate.

Feasibility

Feasible in tertiary ICUs.

Recommendation

Conditional: Consider active fluid removal in fluid-overloaded patients.

Problem

Malnutrition worsens outcomes in sepsis.

Benefit

Maintains gut integrity, reduces infection risk.

Benefit Direction

Positive – improves recovery and reduces complications.

Risk/Harm

Aspiration risk if not monitored.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value nutrition and recovery.

Resource Use

Moderate.

Equity

Widely available in Egyptian ICUs.

Acceptability

High.

Feasibility

Feasible with trained staff.

Recommendation

Strong: Initiate early enteral nutrition when feasible.

Problem

Hyperglycemia common in sepsis.

Benefit

Tight glucose control reduces complications.

Benefit Direction

Positive – reduces morbidity when glucose maintained <180 mg/dL.

Risk/Harm

Hypoglycemia risk with tight control.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value safety.

Resource Use

Low.

Equity

Widely available.

Acceptability

High.

Feasibility

Feasible with monitoring.

Recommendation

Strong: Maintain glucose <180 mg/dL; avoid tight control <110 mg/dL.

Problem

Acute kidney injury common in septic shock.

Benefit

Supports renal function, removes toxins.

Benefit Direction

Positive – improves metabolic control and survival in severe AKI.

Risk/Harm

Hypotension, resource-intensive.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value survival.

Resource Use

High.

Equity

Limited in rural hospitals.

Acceptability

High in tertiary centers.

Feasibility

Feasible in specialized ICUs.

Recommendation

Conditional: Initiate RRT for severe AKI or metabolic derangements.

Problem

Severe metabolic acidosis in sepsis.

Benefit

May improve pH and hemodynamics.

Benefit Direction

Neutral/uncertain – benefit limited to severe acidosis (pH <7.2).

Risk/Harm

Sodium overload, paradoxical intracellular acidosis.

Certainty of Evidence

Low.

Values & Preferences

Patients value stabilization.

Resource Use

Low.

Equity

Widely available.

Acceptability

Moderate.

Feasibility

Feasible with monitoring.

Recommendation

Conditional: Consider in severe acidosis (pH <7.2).

Problem

Anemia common in sepsis.

Benefit

Improves oxygen delivery.

Benefit Direction

Positive – improves oxygenation when Hb <7 g/dL.

Risk/Harm

Transfusion reactions, infection risk.

Certainty of Evidence

Moderate.

Values & Preferences

Patients value survival.

Resource Use

High; requires blood bank.

Equity

Limited in rural hospitals.

Acceptability

High.

Feasibility

Feasible in tertiary centers.

Recommendation

Strong: Transfuse when Hb <7 g/dL; avoid liberal transfusion.

Problem

Sepsis patients at high risk of venous thromboembolism.

Benefit

Reduces the incidence of DVT/PE.

Benefit Direction

Positive – prevents VTE, improves survival.

Risk/Harm

Bleeding risk.

Certainty of Evidence

High.

Values & Preferences

Patients value the prevention of complications.

Resource Use

Low.

Equity

Widely available.

Acceptability

High.

Feasibility

Feasible with standard ICU protocols.

Recommendation

Strong: Provide pharmacologic VTE prophylaxis unless contraindicated.

Definite sepsis

Sepsis is confirmed based on history, clinical examination, and diagnostic testing. An alternative diagnosis is very unlikely.

Probable sepsis

High suspicion for sepsis. Sepsis is the most likely diagnosis based on history, clinical examination, and diagnostic testing. An alternative diagnosis is less likely.

Possible sepsis

Moderate suspicion for sepsis. Sepsis is a possible diagnosis; however, an alternative diagnosis is also likely based on history, clinical examination, and diagnostic testing.

Unlikely sepsis

Low suspicion for sepsis. Clinical assessment is not consistent with sepsis, or an alternate diagnosis is more likely based on history, clinical examination, and diagnostic testing.

Height (m) (feet, inches)

Weigh (kg) (lb.)

1.5 m (4′11′′)

1.7 m (5′7′′)

1.9 m (6′3′′)

50 (110)

1.5

1.5

1.5

60 (132)

1.8

1.8

1.8

70 (154)

2.1

2.1

2.1

80 (176)

1.9

2.4

2.4

90 (200)

2.0

2.4

2.7

100 (220)

2.1

2.5

3.0

110 (242)

2.2

2.6

3.3

120 (264)

2.3

2.7

3.0

130 (287)

2.5

2.8

3.1

140 (309)

2.6

3.0

3.2

150 (331)

2.7

3.1

3.3

160 (353)

2.8

3.2

3.4